Abstract:(5S,8S,10aR)-tert-butyl 5-(tert-butoxycarbonylamino)-2,6-dioxooctahydro-1H-pyrrolo[2,1-d][1,5]oxazocine-8-carboxylate 5, containing an original proline-like moiety, was prepared through Yamaguchi lactonization. However, it was observed that this 8 + 5 bicyclic lactone was spontaneously rearranged to the corresponding 7 + 5 bicyclic lactam under acid conditions, used to remove the Boc/tBu protecting groups. Both core structures were confirmed by one-dimensional and two-dimensional NMR, as well as HRMS. The new proline-like moieties are unknown up to now, and the 7 + 5 bicyclic lactam, much more stable than its precursor, may represent a valuable template to develop constrained non-peptide mimetics.

(R)-(+)-3-hydroxy-2-methoxycarbonyl-8-methyl-8-azoniabicyclo[3.2.1]octanel-bitartrate

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

10-Hexyl-10h-phenothiazine-3-carbaldehyde

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

10-Hexyl-10<i>H</i>-phenothiazine-3-carbaldehyde

(1R,3s,5r,6s)-6-acetoxy-8-methyl-3-(p-tolylsulfonyloxy)-8-azoniabicyclo[3.2.1]octane (2R,3r)-2,3-bis(benzoyloxy)-3-carboxypropanoate

3-[(4-Bromo-2-thienyl)methylenehydrazinocarbonyl]-1h-1,2,4-triazole

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

Acid-induced Atypical Spontaneous Conversion of 5-Amino-2,6-dioxooctahydro-1h-pyrrolo[2,1-d][1,5]oxazocine into 4-(Hydroxymethyl)-2,5-dioxooctahydro-1h-pyrrolo[1,2-d][1,4]diazepine

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

<i>rac</i>-7-[(2<i>E</i>)-But-2-enoyl]-13-chloro-<i>N</i>-cyclohexyl-7,8-dihydro-5<i>H</i>-isochromeno[4,3-<i>c</i>]phenanthridine-8-carboxamide

Octahydro-7a,8′-dimethylspiro[isobenzofuran-4(1H),4′(3′H)-[1H-7,9a]methanocyclohepta[c]pyran]-1′,3,9′(3aH,4′aH)-trione

3-[(2-Hydroxybenzylidene) Hydrazinocarbonyl]-1h-1,2,4-Triazole Ethanol Solvate

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(9S,13R,14R)-7,8-Didehydro-3,4,7-trimeth-oxy-17-methyl-morphinan-6-one.

(4R,5s)-Methyl 1,3-Dibenzyl-5-[(r)-2-(hydroxydiphenylmethyl)pyrrolidine-1-carbonyl]-2-o Xoimidazolidine-4-Carboxylate